Business · 08/11/1995Updated: 10/18/2026 · 1 min read
FDA Amends Notice of Endocrinologic and Metabolic Drugs Advisory Committee Meeting
Summary
The FDA is updating the agenda for an upcoming meeting of the Endocrinologic and Metabolic Drugs Advisory Committee, removing a discussion on probucol and adjusting the meeting schedule, as announced in the Federal Register on October 20, 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →